How next-gen preclinical models can transform cell and gene therapies
David Vallerand, Director of Scientific Engagement for Crown Bioscience, examines the technologies advancing cell and gene therapy drug discovery. … Read More
David Vallerand, Director of Scientific Engagement for Crown Bioscience, examines the technologies advancing cell and gene therapy drug discovery. … Read More
Medicines Discovery Catapult (MDC) and Crown Bioscience have announced a collaboration to deliver an integrated translational biology platform for companies developing radiopharmaceuticals. The global collaboration between MDC and Crown Bioscience will support companies across the radiopharmaceutical pipeline, whether they are advancing radiotherapeutics, exploring new isotopes, or optimising… Read More